Sort
17,828 grants matching “crispr”
Mechanisms of natural killer cell resistance of treatment-persistent residual tumor cells in hematologic malignancies
$406,038Constantine S. Mitsiades · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Gene Editing and Silencing in Phototransduction
$405,911Stephen H Tsang · Columbia University Health Sciences · R01 · FY2024 · EY
Ferroptosis, Cellular Metabolism, and Cancer
$405,771Xuejun Jiang · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Gene Editing and Silencing in Phototransduction
$405,751Stephen H Tsang · Columbia University Health Sciences · R01 · FY2025 · EY
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
$405,748Birgit Knoechel · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
$405,748Birgit Knoechel · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Delineating the synapse coordination pathway
$405,625Adam C Miller · University Of Oregon · R21 · FY2023 · NS
Decoding neural cell fate diversity
$405,625Judith S Eisen · University Of Oregon · R21 · FY2021 · NS
Development of a Genetic Rabbit Model of Kcnh2-Mediated Epilepsy, SUDEP, & Long QT Syndrome Type 2
$405,611David Scott Auerbach · Upstate Medical University · R33 · FY2025 · NS
Functional Validation of Gene Modifications that Protect Beta Cells against Autoimmunity Identified by Genome-Wide CRISPR Cas9 Screening
$405,600Peng Yi · Joslin Diabetes Center · R01 · FY2024 · DK
Biology and therapeutic targeting of zinc finger transcription factors in AML
$405,564Scott A Armstrong · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Multiplexed CRISPRa/i in primary immune cells to elucidate gene regulatory networks underpinning T cell development
$405,497Hao Yuan Kueh · University Of Washington · R21 · FY2025 · AI
CRISPR-based transistors for high throughput multiplexed monitoring of CRISPR-based editing efficiency for Sickle cells disease
$405,375Kiana Aran · Keck Graduate Inst Of Applied Life Scis · R01 · FY2022 · HL
Mechanisms of Primary Cilium Assembly and Disassembly
$405,250David King Breslow · Yale University · R35 · FY2020 · GM
Advancing Nr4a1 as a novel target in cocaine use disorder.
$405,230Elizabeth A Heller · Rafias Llc · R41 · FY2025 · DA
Decoding mechanisms of phenotypic memory in single cells
$405,208Sydney Shaffer · University Of Pennsylvania · DP5 · FY2020 · OD
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML
$405,192Jian Huang · Coriell Institute For Medical Research · R01 · FY2025 · CA
Project 2: Essential metabolic objectives of M. tuberculosis aerobiology
$405,151Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
LncRNA Transcriptional Mechanisms of Coronary Artery Disease Risk
$405,077Thomas None Quertermous · Stanford University · R01 · FY2019 · HL
Genome editing, mRNA suppression and chain termintion as therapy for Lafora Epilepsy
$405,021Berge A Minassian · University Of Kentucky · P01 · FY2016 · NS
ERK-mediated regulation of non-coding RNAs during development and disease
$405,000Swathi Arur · University Of Tx Md Anderson Can Ctr · R35 · FY2025 · GM
E. faecalis Pathogenicity Island
$405,000Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · R01 · FY2016 · AI
Determinants of plague susceptibility and resistance
$405,000Dominique M Missiakas · University Of Chicago · R56 · FY2020 · AI
The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML
$405,000Alan D Friedman · Johns Hopkins University · R01 · FY2019 · HL
Development of epidermal progenitor cell-based therapy for regenerative medicine
$405,000Xiaoyang Wu · University Of Chicago · R01 · FY2019 · OD